Literature DB >> 1402016

Frequencies of lipopolysaccharide core types among clinical isolates of Escherichia coli defined with monoclonal antibodies.

A P Gibb1, G R Barclay, I R Poxton, F di Padova.   

Abstract

Mouse monoclonal antibodies (MAbs) specific for the lipopolysaccharide (LPS) core types R1, R2, and R3 of Escherichia coli and a cross-reactive MAb that binds to the LPS core of almost all E. coli were used in ELISA to determine the frequency of cores resembling R1, R2, and R3 in strains of E. coli isolated from clinical samples (blood and urine specimens) and from the feces of asymptomatic individuals. Of the 180 wild-type isolates, 123 were assigned to R1 core type, 14 to R2, and 18 to R3. Twenty-five wild-type E. coli isolates could not be assigned to a particular core type and may have either an R4 or K12 core or a previously unrecognized core type. R1 core type was associated with O types 1, 4, 6, 8, and 18 and with K1 or K5 capsules. R3 was associated with O15. O75 isolates could be of either R1 or R2 core type.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1402016     DOI: 10.1093/infdis/166.5.1051

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

Review 1.  Lipopolysaccharide endotoxins.

Authors:  Christian R H Raetz; Chris Whitfield
Journal:  Annu Rev Biochem       Date:  2001-11-09       Impact factor: 23.643

2.  Identification of genes required for avian Escherichia coli septicemia by signature-tagged mutagenesis.

Authors:  Ganwu Li; Claudia Laturnus; Christa Ewers; Lothar H Wieler
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

3.  Lipopolysaccharide as an antigen target for the formulation of a universal vaccine against Escherichia coli O111 strains.

Authors:  Maurílio F Santos; Roger R C New; Gabrielle R Andrade; Christiane Y Ozaki; Osvaldo A Sant'Anna; Lucia Mendonça-Previato; Luis R Trabulsi; Marta O Domingos
Journal:  Clin Vaccine Immunol       Date:  2010-09-22

4.  A second outer-core region in Klebsiella pneumoniae lipopolysaccharide.

Authors:  Miguel Regué; Luis Izquierdo; Sandra Fresno; Núria Piqué; Maria Michela Corsaro; Teresa Naldi; Cristina De Castro; Dietmar Waidelich; Susana Merino; Juan M Tomás
Journal:  J Bacteriol       Date:  2005-06       Impact factor: 3.490

5.  Distribution of core oligosaccharide types in lipopolysaccharides from Escherichia coli.

Authors:  K Amor; D E Heinrichs; E Frirdich; K Ziebell; R P Johnson; C Whitfield
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

6.  Silent mischief: bacteriophage Mu insertions contaminate products of Escherichia coli random mutagenesis performed using suicidal transposon delivery plasmids mobilized by broad-host-range RP4 conjugative machinery.

Authors:  Lionel Ferrières; Gaëlle Hémery; Toan Nham; Anne-Marie Guérout; Didier Mazel; Christophe Beloin; Jean-Marc Ghigo
Journal:  J Bacteriol       Date:  2010-10-08       Impact factor: 3.490

7.  Effects of lipopolysaccharide biosynthesis mutations on K1 polysaccharide association with the Escherichia coli cell surface.

Authors:  Natalia Jiménez; Sofya N Senchenkova; Yuriy A Knirel; Giuseppina Pieretti; Maria M Corsaro; Eleonora Aquilini; Miguel Regué; Susana Merino; Juan M Tomás
Journal:  J Bacteriol       Date:  2012-04-20       Impact factor: 3.490

8.  A broadly cross-protective monoclonal antibody binding to Escherichia coli and Salmonella lipopolysaccharides.

Authors:  F E Di Padova; H Brade; G R Barclay; I R Poxton; E Liehl; E Schuetze; H P Kocher; G Ramsay; M H Schreier; D B McClelland
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

9.  In vitro reactivity and growth inhibition of EPEC serotype O111 and STEC serotypes O111 and O157 by homologous and heterologous chicken egg yolk antibody.

Authors:  José Araujo Amaral; Milene Tino De Franco; Lucy Zapata-Quintanilla; Solange Barros Carbonare
Journal:  Vet Res Commun       Date:  2007-12-11       Impact factor: 2.459

10.  Formation of the K30 (group I) capsule in Escherichia coli O9:K30 does not require attachment to lipopolysaccharide lipid A-core.

Authors:  P R MacLachlan; W J Keenleyside; C Dodgson; C Whitfield
Journal:  J Bacteriol       Date:  1993-12       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.